These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
212 related items for PubMed ID: 7563597
1. [Secondary myeloid/natural killer cell acute leukemia appeared in multiple myeloma treated with melphalan]. Kaya H, Nakamura S, Yamazaki H, Kumabashiri I, Ohtake S, Matsuda T. Rinsho Ketsueki; 1995 Jul; 36(7):682-6. PubMed ID: 7563597 [Abstract] [Full Text] [Related]
9. [Multiple myeloma of the IgD-lambda type invading CNS]. Kitamura K, Takeuchi J, Kanbe E, Oka H, Saiki M, Aikawa S, Kura Y, Hatta Y, Yamazaki T, Ito T, Sawada U, Horie T. Rinsho Ketsueki; 2004 Oct; 45(10):1124-8. PubMed ID: 15553049 [Abstract] [Full Text] [Related]
10. Melphalan-prednisone versus alternating combination VAD/MP or VND/MP as primary therapy for multiple myeloma: final analysis of a randomized clinical study. Cavo M, Benni M, Ronconi S, Fiacchini M, Gozzetti A, Zamagni E, Cellini C, Tosi P, Baccarani M, Tura S, Writing Committee of the "Bologna 90" Clinical Trial. Haematologica; 2002 Sep; 87(9):934-42. PubMed ID: 12217805 [Abstract] [Full Text] [Related]
11. [Multiple myeloma preceding myelodysplastic syndrome with eosinophilia and der (1;7)]. Matano S, Kobayashi K, Nakamura S, Yoshida T. Rinsho Ketsueki; 1994 Nov; 35(11):1310-4. PubMed ID: 7823398 [Abstract] [Full Text] [Related]
12. Dexamethasone, paclitaxel, etoposide, cyclophosphamide (d-TEC) and G-CSF for stem cell mobilisation in multiple myeloma. Bilgrami S, Bona RD, Edwards RL, Li Z, Naqvi B, Shaikh A, Furlong F, Fox J, Clive J, Tutschka PJ. Bone Marrow Transplant; 2001 Jul; 28(2):137-43. PubMed ID: 11509931 [Abstract] [Full Text] [Related]
13. Comparison of melphalan and prednisone with vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of multiple myeloma: results of Eastern Cooperative Oncology Group Study E2479. Oken MM, Harrington DP, Abramson N, Kyle RA, Knospe W, Glick JH. Cancer; 1997 Apr 15; 79(8):1561-7. PubMed ID: 9118039 [Abstract] [Full Text] [Related]
15. [Complete remission achieved by L-asparaginase, vincristine and prednisolone (LVP) therapy in secondary leukemia (M5a type) with an MLL gene rearrangement]. Tomita N, Fujita H, Koharazawa H, Maruta A, Kodama F, Yamamoto T, Kobayashi S, Okubo T. Rinsho Ketsueki; 1997 Feb 15; 38(2):135-41. PubMed ID: 9059068 [Abstract] [Full Text] [Related]
16. [A myeloma (IgG-kappa) terminating in acute myelogenous leukemia]. Fujii H, Yashige H, Taniwaki M, Urata Y, Kuzuyama Y, Kitagawa Y, Horishi M, Suyama Y, Miyoshi M. Gan No Rinsho; 1990 Apr 15; 36(5):645-50. PubMed ID: 2109137 [Abstract] [Full Text] [Related]
17. A case of aggressive multiple myeloma with cleaved, multilobated, and monocytoid nuclei, and no serum monoclonal gammopathy. Yeh YA, Pappas AA, Flick JT, Butch AW. Ann Clin Lab Sci; 2000 Jul 15; 30(3):283-8. PubMed ID: 10945569 [Abstract] [Full Text] [Related]
18. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors. Revesz D, Chelghoum Y, Le QH, Elhamri M, Michallet M, Thomas X. Ann Hematol; 2003 Nov 15; 82(11):684-90. PubMed ID: 12928754 [Abstract] [Full Text] [Related]
19. [Acute myelomonocytic leukemia occurred after multiple myeloma treated: a case report]. Wang TY, Huang XO, Xu CG, Chen XC, Wang H. Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Mar 15; 38(2):347-9. PubMed ID: 17441363 [Abstract] [Full Text] [Related]